Yixin CHEN, Ph.D.
1999, B.Sc., Dept. of Biological Engineering, Fuzhou University;
2005, M.Sc., School of Life Sciences, Xiamen University;
2008, Ph.D., School of Life Sciences, Xiamen University.
2009, Assistant Professor, School of Life Sciences, Xiamen University;
2014, Associate Professor, School of Life Sciences, Xiamen University.
Our group is dedicated to study the molecular virology and immunology of human pathogens. Our primary studying subjects are influenza virus, enterovirus, and Epstein-Barr virus and our aims are to reveal the changing antigenicity of target viral proteins; their key epitopes and their biological functions. Our final goals are to develop diagnostic kit, therapeutic antibody, and vaccine against specific viruses. We have maintained a leading position in exploring strategies to elicit broad reactive antibodies.
1. Gui X, Li R, Zhang X, Shen C, Yu H, Guo X, Kang Y, Chen J, Chen H, Chen Y*, Xia N*. An important amino acid in nucleoprotein contributes to influenza A virus replication by interacting with polymerase PB2. Virology, 2014,464-465:11-20.
2. Gui X, Ge P, Wang X, Yang K, Yu H, Zhao Q, Chen Y*, Xia N*. Identification of a highly conserved and surface exposed B-cell epitope on the nucleoprotein of influenza A virus. Journal of Medical Virology, 2014,86:995-1002.
3. Chen Y#, Li C#, He D, Cheng T, Ge S, Shih JW, Zhao Q, Chen P-J, Zhang J, Xia N. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity. Vaccine, 2013,31:425-30.
4. Wu WL, Lau SY, Chen Y, Wang G, Mok BW, Wen X, Wang P, Song W, Lin T, Chan KH, Yuen KY, Chen H. The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses. Antiviral Research, 2012, 93:144-153.
5. Chen Y#, Zheng Q#, Yang K, Zen F, Lau S-Y, Wu WL, Huang S, Zhang J, Chen H, Xia N. Serological survey of antibodies to influenza A viruses on a group of people without a history of influenza vaccination.Clinical Microbiology and Infection, 2011, 17:1347-1349.
6. Zheng Q, Xia L, Wu WL, Zheng Z, Huo Y, Wu J, Liu Y, Yu H, Chen Y, Lau SY, Chen H, Luo W, Xia N. Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses. Antimicrobial Agents and Chemotherapy, 2011,55:1349-1357.
7. Chen Y, Xu F, Gui X, Yang K, Wu X, Zheng Q, Ge S, Yuan Q, Yeo AET, Zhang J, Guan Y, Chen H, Xia N. A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009. Journal of Virological Methods, 2009, 167: 100-102.
8. Chen Y#, Qin K#, Wu WL, Li G, Zhang J, Du H, Ng MH, Shih JWK, Peiris JSM, Guan Y, Chen H, and Xia N. Broad Cross-Protection against H5N1 Avian Influenza Virus Infection by Means of Monoclonal Antibodies that Map to Conserved Viral Epitopes. Journal of Infectious Diseases, 2009,199:49-58.
9. WL Wu#, Chen Y#, Wang P, Song W, Lau SY, Rayner JM, Smith GJD, Webster RG, Peiris JSM, Lin T, Xia N, Guan Y and Chen H. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. Journal of Virology, 2008,82:1798-1807.
10. Chen Y, F Xu, X Fan, H Luo, S Ge, Q Zheng, N Xia, H Chen, Y Guan, and J Zhang. Evaluation of a rapid test for detection of H5N1 avian influenza virus. Journal of Virological Methods, 2008,154:213-215.